Matrix Pharmaceutical Report issue

For profit Phase 2 Phase 3
Founded: Fremont CA United States (1985)
Status: Acquired by Chiron (2002) → now Novartis (2006)

Organization Overview

First Clinical Trial
1995
NCT00002659
First Marketed Drug
1986
chlorhexidine (hibitane)
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MATRIX MEDCL